Key result
Treatment of coronary bifurcation lesions with a paclitaxel-coated balloon and provisional stenting was safe, with 0 major acute coronary events or subacute vessel closures at 4 months.
Why the study?
Does PCI with a paclitaxel-coated balloon catheter followed by provisional bare-metal stenting improve outcomes in patients with coronary artery bifurcation lesions?
Observational (n=20)
Does PCI with a paclitaxel-coated balloon catheter followed by provisional bare-metal stenting improve outcomes in patients with coronary artery bifurcation lesions?
The use of a paclitaxel-coated balloon followed by provisional bare-metal stenting of the main branch appears safe and feasible for coronary bifurcation lesions up to 4 months.
Answers are grounded in this paper and cite their sources.
Supports short-term safety in bifurcation lesions; leaves open efficacy versus drug-eluting stents in randomized trials.
OBJECTIVES: To evaluate outcomes after percutaneous coronary intervention (PCI) with a drug-eluting balloon catheter (paclitaxel-coated) in patients with coronary artery bifurcation lesions. BACKGROUND: The current practice of provisional stenting of the main branch (MB) is reasonable; however, long-term results of side-branch (SB) treatment are suboptimal. The use of drug-eluting stents has not improved these results, regardless of the implantation technique, and could potentially lead to a significant increase in (late) thrombotic events. To evaluate short-term safety and efficacy of a drug-eluting balloon (DEB) in patients with bifurcation lesions followed by provisional stenting of the main branch, we set up the DEBIUT Registry. METHODS: This registry enrolled 20 eligible patients with coronary artery bifurcation lesions. Patients received a PCI with a paclitaxel-coated balloon catheter, followed by provisional stenting of the MB with a bare-metal stent. Acute angiographic and clinical follow-up were performed after 1 and 4 months. RESULTS: The procedure was successful in all patients. The use of sequential predilatation with DEB was safe and well tolerated. No acute or subacute closure of side branches occurred after treating with DEB. All patients were treated according to the provisional stenting technique; no stents were placed in the SB. At 4-month follow-up no major acute coronary events and no subacute vessel closure were reported. CONCLUSION: The use of a drug-eluting balloon in patients with bifurcation lesions was effective and safe up to 4 months following PCI in patients with coronary artery bifurcation lesions.
No takes yet. Share an insight, caveat, or question.
Fanggiday et al. (2008) conducted an observational in Coronary artery bifurcation lesions (n=20). Paclitaxel-coated drug-eluting balloon with provisional stenting was evaluated on Major acute coronary events and subacute vessel closure. Treatment of coronary bifurcation lesions with a paclitaxel-coated balloon and provisional stenting was safe, with 0 major acute coronary events or subacute vessel closures at 4 months.
Synapse has enriched 10 related papers. Consider them for comparative context: